Envoy Medical settles Atlas SPAC redemption suit; all claims dismissed with prejudice, no payment owed

Envoy Medical, Inc.

Envoy Medical entered a Dismissal Agreement on October 6, 2026 ending Delaware Court of Chancery litigation brought by Atlas Merchant Capital SPAC Fund I LP.
Atlas had alleged it was not allowed to redeem its Class A Common Stock in the Company's September 2023 business combination transaction.
All of Atlas' claims will be dismissed with prejudice and no further proceedings will occur in the Litigation.
Neither Envoy Medical nor any other defendant is required to make any payment to Atlas under the Dismissal Agreement.
8-K signed October 7, 2026 by CEO Brent Lucas; Exhibit 104 cover page XBRL only, no financial statements filed.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.